How Long Does Semaglutide Take to Work?

Semaglutide starts reducing appetite from week one, though the effect builds steadily as the dose increases over several months.
In the STEP 1 trial, participants lost an average of around 15% of their body weight over 68 weeks at the 2.4mg maintenance dose.
Weight loss tends to slow and plateau after roughly 60–72 weeks as the body adjusts — this is a normal biological response, not a sign the medicine has stopped working.
Semaglutide (Wegovy) is a prescription-only medicine; a GPhC-registered prescriber must assess your suitability before treatment can begin.

Semaglutide begins working from your very first dose, but meaningful weight loss typically becomes noticeable after four to eight weeks. Most people see the clearest changes once they reach a higher maintenance dose, which can take several months of gradual titration. These are prescription-only medicines that require a clinical assessment before a prescriber can determine whether they're right for you. If you're trying to make sense of the timeline, here's what the clinical picture actually looks like.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The semaglutide timeline, phase by phase

Does semaglutide do anything in the first few weeks?

Yes, though the changes are subtle at first. Semaglutide is a GLP-1 receptor agonist, meaning it mimics a gut hormone that signals fullness to the brain, slows how quickly the stomach empties, and damps down appetite. Those effects are present from the very first injection. What most people notice early on is that they feel full sooner at meals and think about food less between them. The scales may not shift dramatically in week one or two, and that's expected.

Treatment starts at a low dose specifically to let your body adjust. That first-dose caution isn't there to hold back results — it's there to reduce the nausea and digestive discomfort that can come with starting any GLP-1 medicine. The mechanism behind semaglutide means appetite suppression is genuine from the outset; the titration schedule just manages how intensely it hits.

A question our prescribers hear most weeks is: "I'm on the starter dose and nothing seems to be happening, is it working?" Almost always, something is. The full effect unfolds as the dose rises.

When do most people start losing noticeable weight?

For many people, the four-to-twelve-week window is when weight loss becomes more tangible. By this point the dose has usually increased at least once, appetite suppression is stronger, and calorie intake has fallen more consistently. Clothes may feel looser before the number on the scale moves as dramatically as expected, partly because of changes in fluid balance and activity levels.

The STEP 1 trial (published in the New England Journal of Medicine) followed 1,961 adults over 68 weeks at the 2.4mg maintenance dose of semaglutide. Average weight reduction was around 15%. That figure accumulated gradually, with participants continuing to lose weight through much of the trial period rather than dropping quickly and flattening out.

It's worth reading more about the typical semaglutide timeline week by week if you want a closer look at when different effects tend to peak. The short version: steady progress over months, not a dramatic overnight shift.

Does semaglutide eventually stop working?

Not exactly, but weight loss does slow. After roughly 60–72 weeks at a stable maintenance dose, most people reach a new set point where the body adapts to the lower calorie intake and weight plateaus. This is a well-documented biological pattern, not a sign the medicine has become ineffective. Appetite suppression is still present; the deficit has simply narrowed as the body recalibrates its energy expenditure.

The NHS patient guidance on semaglutide and tirzepatide explains that these medicines work best alongside a reduced-calorie diet and increased physical activity, both of which remain important throughout treatment, not just at the start. If your progress stalls, the right conversation is with your prescriber, who can review whether a dose adjustment or other changes make clinical sense.

Stopping treatment abruptly often reverses weight loss over time. If you're thinking about that question, our page on stopping Wegovy suddenly covers what the evidence says and what to discuss with your clinical team.

What affects how quickly semaglutide works for you?

Starting weight, metabolic rate, how consistently the medicine is taken, diet quality, activity levels, and how quickly you can tolerate dose increases all play a role. People who experience significant nausea may stay on lower doses for longer, which delays the point at which the stronger appetite-suppression effect kicks in, but titrating more slowly is sometimes the right clinical choice, not a compromise.

The NHS semaglutide medicines page notes that the medicine is taken once a week and that missing doses or taking them irregularly can reduce its effectiveness. Consistency matters more than people often expect with a once-weekly injection, and if you're wondering how to fit injections around a busy schedule, our guide on taking Wegovy to work covers practical ways to manage your doses on working days. There's also individual biological variation: two people on the same dose, same diet, same activity level can see different results, and that's genuinely normal.

For a fuller picture of how the medicine fits into a private treatment pathway, the Wegovy overview covers eligibility, the licensed doses available in the UK, and what clinical review looks like at each stage. Cost is sometimes part of the planning conversation too; the Wegovy pricing page sets out what private treatment typically involves financially.

If you'd like to discuss your own circumstances with a prescriber, starting a free consultation with our clinical team is the straightforward next step.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions